JSR Life Sciences
Overview
JSR Life Sciences brings together the deep biochemical knowledge and understanding of human disease, expertise in drug discovery and development, and access to capital into a single, integrated framework that creates value for our customers . JSR supports the drug discovery and development needs of our partners with tailored solutions that identifies and applies the right tools and technologies to support their unique therapeutic programs . From de-risking molecule selection and accelerating biologic development timelines, to increasing clinical success rates and developing in vitro diagnostics, JSR Life Sciences is committed to guiding our customers' innovative science along the path to becoming life-saving medicines .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Optimeos Life Sciences | Aug 2023 | Seed | Lead |
| Aqualung Therapeutics Corporation | Oct 2022 | Series A | Lead |
| Inhalon Biopharma Inc. | Jun 2022 | Series A | Lead |
| Aqualung Therapeutics Corporation | Jan 2022 | Convertible Debt | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.